New hope for aggressive brain cancer: niraparib takes on standard chemo
Disease control
Recruiting now
This study tests whether a drug called niraparib works better than the standard chemotherapy temozolomide for adults with a newly-diagnosed, aggressive type of brain cancer called glioblastoma that has a specific genetic marker (MGMT unmethylated). About 450 participants will be …
Phase: PHASE3 • Sponsor: Ivy Brain Tumor Center • Aim: Disease control
Last updated Jun 01, 2026 18:04 UTC